On Friday, media company Grabien was suspended from Twitter for posting a quote from a congressman regarding COVID-19 treatments.
Grabien founder Tom Elliott confirmed the suspension in a Tweet on Friday afternoon, stating that a quote from Rep. Andy Biggs was the offending post that brought about the suspension.
"VIDEO - Re. Biggs: Big Pharma Won't Consider Therapeutics Like HCQ or Ivermectin Because of Economic Interests," the post in question reads. Attached was a video with Biggs' statement.
Twitter claimed that the post "violated the policy on spreading misinformation and potentially harmful information related to COVID-19."
The Centers for Disease Control and Prevention has advised against the use of ivermectin or hydroxychloroquine to treat COVID-19.
Elliott called the suspension "next-level Twitter absurdity," drawing parallels to other questionable suspensions he has been handed by the social media giant in the past.
"Obviously, in this case, quoting an elected leader on an issue that matters to everyone is important and newsworthy, regardless of whether you agree," wrote Elliott, who noted "And I can't help but add that his basic point was once mainstream among progressives."
Elliott said that he has appealed Twitter's decision, noting the above argument in his appeal form, "However I have no confidence in Twitter doing the right thing and acknowledging this tweet did not violate its terms & conditions."
As of January 1, Grabien's account is still accessible on Twitter, but the company has been locked out due to the suspension.
Join and support independent free thinkers!
We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.
Remind me next month
To find out what personal data we collect and how we use it, please visit our Privacy Policy